Literature DB >> 31162709

Optimal designs in three-level cluster randomized trials with a binary outcome.

Jingxia Liu1,2, Lei Liu2, Graham A Colditz1.   

Abstract

Cluster randomized trials (CRTs) were originally proposed for use when randomization at the subject level is practically infeasible or may lead to a severe estimation bias of the treatment effect. However, recruiting an additional cluster costs more than enrolling an additional subject in an individually randomized trial. Under budget constraints, researchers have proposed the optimal sample sizes in two-level CRTs. CRTs may have a three-level structure, in which two levels of clustering should be considered. In this paper, we propose optimal designs in three-level CRTs with a binary outcome, assuming a nested exchangeable correlation structure in generalized estimating equation models. We provide the variance of estimators of three commonly used measures: risk difference, risk ratio, and odds ratio. For a given sampling budget, we discuss how many clusters and how many subjects per cluster are necessary to minimize the variance of each measure estimator. For known association parameters, the locally optimal design is proposed. When association parameters are unknown but within predetermined ranges, the MaxiMin design is proposed to maximize the minimum of relative efficiency over the possible ranges, that is, to minimize the risk of the worst scenario.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  cluster randomized trial (CRT); dissemination and implementation; generalized estimating equation (GEE); intracluster correlation coefficient (ICC); nested correlation structure

Mesh:

Year:  2019        PMID: 31162709      PMCID: PMC6905388          DOI: 10.1002/sim.8153

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  23 in total

1.  Maximin D-optimal designs for longitudinal mixed effects models.

Authors:  Mario J N M Ouwens; Frans E S Tan; Martijn P F Berger
Journal:  Biometrics       Date:  2002-12       Impact factor: 2.571

2.  Optimal designs for clinical trials with second-order polynomial treatment effects.

Authors:  Bjorn Winkens; Hubert J A Schouten; Gerard J P van Breukelen; Martijn P F Berger
Journal:  Stat Methods Med Res       Date:  2007-08-14       Impact factor: 3.021

3.  Quality of life (QoL) in metastatic breast cancer patients with maintenance paclitaxel plus gemcitabine (PG) chemotherapy: results from phase III, multicenter, randomized trial of maintenance chemotherapy versus observation (KCSG-BR07-02).

Authors:  Yeon Hee Park; Kyung Hae Jung; Seock-Ah Im; Joo Hyuk Sohn; Jungsil Ro; Jin-Hee Ahn; Sung-Bae Kim; Byung-Ho Nam; Do Youn Oh; Sae-Won Han; Soohyeon Lee; In Hae Park; Keun Seok Lee; Jee Hyun Kim; Seok Yun Kang; Moon Hee Lee; Hee Sook Park; Sook Young Woo; Sin-Ho Jung; Jin Seok Ahn; Young-Hyuck Im
Journal:  Breast Cancer Res Treat       Date:  2015-06-02       Impact factor: 4.872

4.  The Effects of Surgery Type and Chemotherapy on Early-Stage Breast Cancer Patients' Quality of Life Over 2-Year Follow-up.

Authors:  Donna B Jeffe; Maria Pérez; Emily F Cole; Ying Liu; Mario Schootman
Journal:  Ann Surg Oncol       Date:  2015-10-28       Impact factor: 5.344

5.  Quality of life and satisfaction with outcome among prostate-cancer survivors.

Authors:  Martin G Sanda; Rodney L Dunn; Jeff Michalski; Howard M Sandler; Laurel Northouse; Larry Hembroff; Xihong Lin; Thomas K Greenfield; Mark S Litwin; Christopher S Saigal; Arul Mahadevan; Eric Klein; Adam Kibel; Louis L Pisters; Deborah Kuban; Irving Kaplan; David Wood; Jay Ciezki; Nikhil Shah; John T Wei
Journal:  N Engl J Med       Date:  2008-03-20       Impact factor: 91.245

6.  Sample size considerations for GEE analyses of three-level cluster randomized trials.

Authors:  Steven Teerenstra; Bing Lu; John S Preisser; Theo van Achterberg; George F Borm
Journal:  Biometrics       Date:  2010-12       Impact factor: 2.571

7.  Maximin optimal designs for cluster randomized trials.

Authors:  Sheng Wu; Weng Kee Wong; Catherine M Crespi
Journal:  Biometrics       Date:  2017-02-09       Impact factor: 1.701

8.  Effects of a Web-Based Intervention for Stress Reduction in Primary Care: A Cluster Randomized Controlled Trial.

Authors:  Michael Mehring; Max Haag; Klaus Linde; Stefan Wagenpfeil; Antonius Schneider
Journal:  J Med Internet Res       Date:  2016-02-12       Impact factor: 5.428

9.  Systems intervention to promote colon cancer screening in safety net settings: protocol for a community-based participatory randomized controlled trial.

Authors:  Aimee S James; Veronica Richardson; Jean S Wang; Enola K Proctor; Graham A Colditz
Journal:  Implement Sci       Date:  2013-06-03       Impact factor: 7.327

10.  Effect of Behavior Modification on Outcome in Early- to Moderate-Stage Chronic Kidney Disease: A Cluster-Randomized Trial.

Authors:  Kunihiro Yamagata; Hirofumi Makino; Kunitoshi Iseki; Sadayoshi Ito; Kenjiro Kimura; Eiji Kusano; Takanori Shibata; Kimio Tomita; Ichiei Narita; Tomoya Nishino; Yoshihide Fujigaki; Tetsuya Mitarai; Tsuyoshi Watanabe; Takashi Wada; Teiji Nakamura; Seiichi Matsuo
Journal:  PLoS One       Date:  2016-03-21       Impact factor: 3.240

View more
  1 in total

1.  Power considerations for generalized estimating equations analyses of four-level cluster randomized trials.

Authors:  Xueqi Wang; Elizabeth L Turner; John S Preisser; Fan Li
Journal:  Biom J       Date:  2021-12-13       Impact factor: 1.715

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.